Log in to save to my catalogue

The G2 checkpoint inhibitor CBP-93872 increases the sensitivity of colorectal and pancreatic cancer...

The G2 checkpoint inhibitor CBP-93872 increases the sensitivity of colorectal and pancreatic cancer...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1903916163

The G2 checkpoint inhibitor CBP-93872 increases the sensitivity of colorectal and pancreatic cancer cells to chemotherapy

About this item

Full title

The G2 checkpoint inhibitor CBP-93872 increases the sensitivity of colorectal and pancreatic cancer cells to chemotherapy

Publisher

United States: Public Library of Science

Journal title

PloS one, 2017-05, Vol.12 (5), p.e0178221

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

CBP-93872 suppresses maintenance of DNA double-stranded break-induced G2 checkpoint, by inhibiting the pathway between ataxia-telangiectasia mutated (ATM) and ATM- and Rad3-related (ATR) activation. To examine the potential use of CBP-93872 for clinical applications, we analyzed the synergistic effects of platinum-containing drugs, oxaliplatin and...

Alternative Titles

Full title

The G2 checkpoint inhibitor CBP-93872 increases the sensitivity of colorectal and pancreatic cancer cells to chemotherapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_1903916163

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1903916163

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0178221

How to access this item